Effects of Additional Administration of Low-Dose Indapamide on Patients With Hypertension Treated With Angiotensin II Receptor Blocker

Abstract

Background: Low-dose thiazide or thiazide-like diuretics have proven useful for the management of blood pressure in patients older than 65 years (elderly group). However, there are few reports about the antihypertensive effects of antihypertensive diuretic agents in patients younger than 65 years (middle-aged group). So, we evaluated the efficacy of low-dose indapamide on blood pressure. Methods: Indapamide(1 mg) was given daily for 3 months and was then given every other day for 3 months to patients whose hypertension was poorly controlled with angiotensin II receptor blocker (ARB)-based treatment. Results: After daily administration of indapamide, blood pressure was significantly decreased in both the middle-aged and elderly groups. Blood pressure was not significantly changed by every-other-day administration compared with that observed after daily administration in either group. The rate of attainment of the target blood pressure was 90.3% and 85.7% in the middle-aged and elderly groups, respectively. The serum uric acid levels were reduced after every-other-day administration compared to daily administration but tended to be higher than the levels at the baseline in both groups. Conclusions: The addition of low-dose indapamide is a useful strategy for the management of hypertension, as it reduced blood pressure without marked side effects.

Keywords

Indapamide low-dose hypertension thiazide-like diuretic combination therapy middle-aged

References

Japanese society of hypertension. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32(1):1-107.

Mori H. , Ukai H. , Yamamoto H. , et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res. 2006;29(3):143-151.

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997.

Beckett NS , Peters R. , Fletcher AE , et al, for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-98.

Franco OH , Peeters A. , Bonneux L. , Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension. 2005;46(2): 280-286.

Saruta T. , Ogihara T. , Matsuoka H. , et al. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension. Hypertens Res. 2007;30(8):729-739.

Cockcroft DW , Gault MH Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.

Caruso FS , Szabadi RR , Vukovich RA Pharmacokinetics and clinical pharmacology of indapamide. Am Heart J. 1983;106(1 pt 2):212-220.

Miyazaki M. , Morishita S. , Toda N. Vasodilator effect of indapamide in dog mesenteric vasculature. Jpn J Pharmacol. 1985; 39(3):402-405.

10.

Uehara Y. , Kawabata Y. , Shirahase H. , et al. Radical scavenging properties of indapamide and renal protection in dahl salt-sensitive rats. Hypertens Res. 1992;15(1):17-26.

11.

Uehara Y. , Shirahase H. , Nagata T. , et al. Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension. 1990 ;15(2):216-224.

12.

Fiddes R. , Blumenthal J. , Dawson JE , et al. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension. J Hum Hypertens. 1997;11(4):239-244.

13.

PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033-1041.

14.

Gosse P. , Sheridan DJ , Zannad F. , et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enarapril 20 mg: the LIVE study. J Hypertens. 2000;18(10):1465-1475.

15.

Marre M. , Puig JG , Kokot F. , et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR study . J Hypertens. 2004;22(8):1613-1622.

16.

Franklin SS , Larson MG , Khan SA , et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation . 2001;103(9): 1245-1249.

17.

Peterson JC , Adler S. , Burkart JM , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995; 123(10):754-762.

18.

Hamada T. , Ichida K. , Hosoyamada M. , et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. Am J Hypertens. 2008;21(10):1157-1162.

19.

Coronel F. , Cigarrán S. , García-Mena M. , et al. Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI. Nefrologia. 2008; 28(1):56-60.

20.

Inaba M. , Noguchi Y. , Yamamoto T. , et al. Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens Res. 2004;27(3):141-145.